Sholehvar David 4
4 · NEOGENOMICS INC · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Sholehvar David
President, Clinical Services
Transactions
- Award
Stock Option (Right to Buy)
2022-08-01+25,826→ 25,826 totalExercise: $10.12Exp: 2029-08-01→ Common Stock (25,826 underlying) - Award
Common Stock
2022-08-01+12,352→ 43,216 total
Holdings
- 66,372
Stock Option (Right to Buy)
Exercise: $12.15Exp: 2029-04-01→ Common Stock (66,372 underlying)
Footnotes (3)
- [F1]On August 1, 2022, Dr. Sholehvar was granted 12,352 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On August 1, 2022, Dr. Sholehvar was granted 25,826 stock options. These options vest ratably over the first four anniversary dates of the grant date.